FDA Needs New Regulatory Model In Face Of Globalization, Woodcock Says
This article was originally published in The Tan Sheet
Executive Summary
The FDA requires a new regulatory model to confront issues presented by globalization, which will include reliance on foreign regulators, according to agency Chief Medical Officer Janet Woodcock
You may also be interested in...
Ex-FDA Chief Crawford Calls For Dramatic Changes In Global Harmonization
A new global organization should be established to promote the harmonization of regulatory requirements between countries, according to former FDA Commissioner Lester Crawford
Ex-FDA Chief Crawford Calls For Dramatic Changes In Global Harmonization
A new global organization should be established to promote the harmonization of regulatory requirements between countries, according to former FDA Commissioner Lester Crawford
Ex-FDA Chief Crawford Calls For Dramatic Changes In Global Harmonization
A new global organization should be established to promote the harmonization of regulatory requirements between countries, according to former FDA Commissioner Lester Crawford